Viewing Study NCT00413140



Ignite Creation Date: 2024-05-05 @ 5:14 PM
Last Modification Date: 2024-10-26 @ 9:29 AM
Study NCT ID: NCT00413140
Status: COMPLETED
Last Update Posted: 2006-12-19
First Post: 2006-12-18

Brief Title: Non-Invasive Biomarkers in Cystic Fibrosis
Sponsor: Maastricht University Medical Center
Organization: Maastricht University Medical Center

Study Overview

Official Title: Biomarkers in Exhaled Breath Indicate Presence Control and Severity of Cystic Fibrosis
Status: COMPLETED
Status Verified Date: 2003-11
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Background Chronic airway inflammation is present in cystic fibrosis Non-invasive inflammometry may be useful in disease management

Objective We studied 1 the ability of fractional exhaled nitric oxide and inflammatory markers acidity nitrite nitrate hydrogen peroxide 8-isoprostane interferon-γ tumor necrosis factor-α interleukin-2-4-5-10 in exhaled breath condensate to discriminate between cystic fibrosis and control children and 2 the relationship of biomarkers with control and severity of cystic fibrosis

Methods In 98 children 48 cystic fibrosis 50 controls condensate was collected using a glass condenser Exhaled nitric oxide was measured using the NIOX
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None